Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
An update on a study evaluating the acceptability, appropriateness, and usability of a prognostic calculator specifically for metastatic bre…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy
A clinical trial update describes the development of a remote monitoring model for patients with HR-positive, HER2-negative breast cancer tr…
-
FDA approval · 2025-09-23FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for leuprolide acetate (generic) submitted by Eugia US LLC under an ANDA.
-
FDA label_change · 2025-09-23FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for Leuprolide acetate filed by NorthStar RxLLC, indicating an update to the product labeling.
-
FDA approval · 2025-09-23FDA Approved: TRIPTODUR — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRIPTODUR (triptorelin) from Azurity Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2025-09-23FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
FDA approved a supplemental application for ZOLADEX (goserelin) submitted by TerSera Therapeutics LLC. The approval updates the label to ref…
-
FDA approval · 2025-09-23FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Leuprolide acetate from Amneal Pharmaceuticals LLC, granting approval for a generic version of t…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Individuals on Hormone Therapy Breast Cancer Screening Pilot
A clinical trial update indicates a breast cancer screening study for individuals on hormone therapy is currently recruiting. No results are…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a trastuzumab-based CAR-T therapy targeting HER2-positive advanced breast cancer and other solid tumors…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council
A completed retrospective study sponsored by AstraZeneca aims to estimate the prevalence of HER2-low status among unresectable or metastatic…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer
A clinical trial is examining the relationship between COVID-19 and radiation pneumonitis in patients with breast cancer; the study is not y…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating azacitidine in combination with QPOP and CURATE.AI for solid tumors is currently recruiting, co…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Mechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast Cancer
A mechanistic study investigating SPARC's regulation of neutrophil extracellular trap formation in the brain metastasis microenvironment of …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Taking AIM at Breast Cancer [NA]
Dana-Farber Cancer Institute's breast cancer trial (NCT04720209) is currently active but not recruiting, spanning stages I–III. No enrollmen…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Bergonie Institute Breast Cancer Database
Recruitment update for the Bergonié Institute Breast Cancer Database clinical trial (NCT02893761) sponsored by Institut Bergonié, focused on…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire
A clinical trial evaluating subjectively perceived pelvic floor function in patients with gynecologic tumors or breast cancer undergoing sys…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes [NA]
A clinical trial update describing research on molecular characterization and subtypes of HER2-positive breast cancer; the study is not yet …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Intra-Operative Radiation Registry
The Intra-Operative Radiation Registry trial, sponsored by Albert Einstein College of Medicine, is currently recruiting patients with breast…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition [NA]
A completed clinical trial evaluates a family-based intervention to study the effects of environmental exposures on breast tissue compositio…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA) [Phase 1, Phase 2]
This document reports the status of a Phase 1/2 clinical trial evaluating trifluridine/tipiracil (Lonsurf) in metastatic breast cancer patie…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Effect of Dexmedetomidine Infusion on Post Anesthesia Discharge Time [NA]
A completed clinical trial evaluating whether dexmedetomidine infusion affects postoperative discharge time after breast cancer surgery.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
A clinical trial is examining whether circulating tumor DNA (ctDNA) assessment can predict response to neoadjuvant therapy in breast cancer …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy [Phase 2]
A Phase 2 clinical trial update describing a blood-based tumor DNA test to identify HR+/HER2-low metastatic breast cancer patients who may b…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer. (KDOGCOV) [NA]
A completed clinical trial sponsored by Institut Curie investigates volatile organic compounds related to the olfactory signature of breast …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
This completed clinical trial update analyzes treatment patterns and clinical outcomes of palbociclib combinations in hormone receptor-posit…